Logo image of AFI

ARMSTRONG FLOORING INC (AFI) Stock Fundamental Analysis

NYSE:AFI - New York Stock Exchange, Inc. - US04238R1068 - Common Stock

0.3512  -0.03 (-7.26%)

After market: 0.355 +0 (+1.08%)

Fundamental Rating

1

AFI gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 41 industry peers in the Building Products industry. AFI has a bad profitability rating. Also its financial health evaluation is rather negative. AFI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AFI has reported negative net income.
AFI Yearly Net Income VS EBIT VS OCF VS FCFAFI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M -50M -100M -150M

1.2 Ratios

Industry RankSector Rank
ROA -10.25%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AFI Yearly ROA, ROE, ROICAFI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -10 -20 -30 -40

1.3 Margins

Industry RankSector Rank
OM -12.51%
PM (TTM) -8.16%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AFI Yearly Profit, Operating, Gross MarginsAFI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20 -20

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, AFI has more shares outstanding
Compared to 1 year ago, AFI has a worse debt to assets ratio.
AFI Yearly Shares OutstandingAFI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M
AFI Yearly Total Debt VS Total AssetsAFI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.00, we must say that AFI is in the distress zone and has some risk of bankruptcy.
AFI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0
ROIC/WACCN/A
WACCN/A
AFI Yearly LT Debt VS Equity VS FCFAFI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M 400M 600M

2.3 Liquidity

AFI has a Current Ratio of 0.93. This is a bad value and indicates that AFI is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.32 indicates that AFI may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.32
AFI Yearly Current Assets VS Current LiabilitesAFI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.54% over the past year.
Looking at the last year, AFI shows a quite strong growth in Revenue. The Revenue has grown by 11.13% in the last year.
Measured over the past years, AFI shows a decrease in Revenue. The Revenue has been decreasing by -1.76% on average per year.
EPS 1Y (TTM)17.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.78%
Revenue 1Y (TTM)11.13%
Revenue growth 3Y-3.72%
Revenue growth 5Y-1.76%
Sales Q2Q%14.25%

3.2 Future

Based on estimates for the next years, AFI will show a very negative growth in Earnings Per Share. The EPS will decrease by -22.08% on average per year.
Based on estimates for the next years, AFI will show a quite strong growth in Revenue. The Revenue will grow by 13.07% on average per year.
EPS Next Y-105.32%
EPS Next 2Y-44.52%
EPS Next 3Y-27.83%
EPS Next 5Y-22.08%
Revenue Next Year87.49%
Revenue Next 2Y40.41%
Revenue Next 3Y28.15%
Revenue Next 5Y13.07%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AFI Yearly Revenue VS EstimatesAFI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
AFI Yearly EPS VS EstimatesAFI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AFI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AFI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AFI Price Earnings VS Forward Price EarningsAFI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2.75
AFI Per share dataAFI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

A cheap valuation may be justified as AFI's earnings are expected to decrease with -27.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-44.52%
EPS Next 3Y-27.83%

More info and screens

0

5. Dividend

5.1 Amount

AFI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARMSTRONG FLOORING INC

NYSE:AFI (5/20/2022, 8:04:01 PM)

After market: 0.355 +0 (+1.08%)

0.3512

-0.03 (-7.26%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)04-08 2022-04-08/bmo
Earnings (Next)06-03 2022-06-03/bmo
Inst Owners0%
Inst Owner Change0%
Ins Owners6.8%
Ins Owner Change0%
Market Cap7.65M
Analysts76.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.04
P/tB N/A
EV/EBITDA -2.75
EPS(TTM)-2.39
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS29.84
BVpS9.15
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.25%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -12.51%
PM (TTM) -8.16%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.32
Altman-Z 0
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.78%
EPS Next Y-105.32%
EPS Next 2Y-44.52%
EPS Next 3Y-27.83%
EPS Next 5Y-22.08%
Revenue 1Y (TTM)11.13%
Revenue growth 3Y-3.72%
Revenue growth 5Y-1.76%
Sales Q2Q%14.25%
Revenue Next Year87.49%
Revenue Next 2Y40.41%
Revenue Next 3Y28.15%
Revenue Next 5Y13.07%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A